Showing results (321-330 of 602) with videos related to
Sort By:
Pageof 61
Leukemia Research|March 21, 2016
The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myelomaWilson I Gonsalves, Michael M Timm, S Vincent Rajkumar, et al.Bone Marrow Transplantation|November 19, 2020
Depth of response prior to autologous stem cell transplantation predicts survival in light chain amyloidosisIuliana Vaxman, M Hasib Sidiqi, Abdullah S Al Saleh, et al.Bone Marrow Transplantation|June 14, 2019
The impact of re-induction prior to salvage autologous stem cell transplantation in multiple myelomaKevin C Miller, Morie A Gertz, Francis K Buadi, et al.Iscience|June 21, 2021
Combined epigenetic and metabolic treatments overcome differentiation blockade in acute myeloid leukemiaBarry M Zee, Kamrine E Poels, Cong-Hui Yao, et al.Nature Cell Biology|July 3, 2019
Subclonal cooperation drives metastasis by modulating local and systemic immune microenvironmentsMichalina Janiszewska, Doris P Tabassum, Zafira Castaño, et al.Nature Medicine|April 8, 2015
Studying clonal dynamics in response to cancer therapy using high-complexity barcodingHyo-eun C Bhang, David A Ruddy, Viveksagar Krishnamurthy Radhakrishna, et al.JCI Insight|April 22, 2021
The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancerMichalina Janiszewska, Shayna Stein, Otto Metzger Filho, et al.Blood|May 22, 2012
Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experienceAnita D'Souza, Martha Lacy, Morie Gertz, et al.Bone Marrow Transplantation|August 18, 2018
Comparable outcomes using propylene glycol-free melphalan for autologous stem cell transplantation in multiple myelomaKevin C Miller, Morie A Gertz, Francis K Buadi, et al.American Journal of Hematology|September 28, 2010
Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugsAngela Dispenzieri, David Dingli, Shaji K Kumar, et al.Pageof 61